Priapism: evolution of management in 48 patients in a 22-year series.
The choice of an effective method to treat priapism is challenging because precise causes in the majority of patients have not been well defined. A review of 48 patients treated during a 22-year period shows evolution of a regimen of management that has yielded a high percentage of success. Idiopathic priapism and sickle cell disease accounted for 81 per cent of the subjects. An evaluation should include a medication history, a search for specific diseases, as well as a thorough physical examination to detect possible etiologic factors. The explanation for the frequent association of fever deserves further investigation. Initial therapy consisting of aspiration and irrigation, and intermittent pneumatic cuff compression should be undertaken for a trial period of 12 to 36 hours, repeating the aspiration 2 or 3 times if necessary. The failure of priapism to resolve after such treatment is an indication for a shunt operation. Patients with known etiology should be treated specifically for the primary disease and usually more conservatively for priapism. Resolution occurred in all patients and approximately 50 per cent regained sexual potency.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000755:Anemia, Sickle Cell / Q000150:complications; D000925:Anticoagulants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000627:therapeutic use; D007938:Leukemia / Q000150:complications; D008297:Male; D008702:Methaqualone / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D010413:Penis / Q000293:injuries; D010640:Phenothiazines; D011317:Priapism / Q000139:chemically induced / Q000209:etiology / Q000601:surgery / Q000628:therapy; D013396:Suction; D007507:Therapeutic Irrigation; D014044:Tolbutamide / Q000627:therapeutic use
D000925:Anticoagulants; D014150:Antipsychotic Agents; D005938:Glucocorticoids; D010640:Phenothiazines; D006830:Hydralazine; D008702:Methaqualone; D014044:Tolbutamide; D006145:Guanethidine